Resumen

VALDES URRUTIA, Lourdes. Ventajas de la gammaglobulina endovenosa en el síndrome de Guillain-Barré en el niño. Rev Cubana Pediatr [online]. 2002, vol.74, n.4, pp. 0-0. ISSN 1561-3119.

Twenty two children suffering from Guillain-Barré´s syndrome (GBS) were examined and further evaluated in their clinical course according to the treatment. Males prevailed (59.1%). Average age was 7 years. These children had previous infections, being acute respiratory infections the most frequent. Proteinrachia was observed in 21 patients (95,2%). One group (group A with 8 patients) was given steroids and the other group (group B with 14 patients) was intravenously administered Cuban immunoglobulin. The clinical improvement and the independent walking ability of the patients were evaluated in both groups. The patients included in group A showed clinical improvement after 17,3 days as an average and a maximum average length of 57.1 days to reach the ambulatory capacity. On the other hand, the group B started improvement at an average of 8.3 days and reached walking capacity after 25,42 days. The statistical analysis was highly significant (p=.0002).

Palabras clave : GUILLAIN - BARRE SYNDROME [drug therapy]; GAMMAGLOBULINS [therapeutic use]; INJECTIONS; INTRAVENOSUS; STEROIDS [therapeutic use]; IMMUNOGLOBULINS [drug therapy]; CHILD.